BusinessNew Independent Assessment of Clinical Researchers Aimed at Protecting Public HealthBy Nasdaq OMXSep 29, 2016, 4:07 PM UTC
BusinessOcera to Present at the 15th Annual Needham Healthcare ConferenceBy Nasdaq OMXApr 5, 2016, 8:25 PM UTC
BusinessFlexion Therapeutics Announces Presentation of Results From Pivotal Phase 2b and Phase 3 Clinical Trials for Zilretta™ at Osteoarthritis Research Society International (OARSI) 2016 World CongressBy Nasdaq OMXApr 4, 2016, 11:00 AM UTC
BusinessFlexion Therapeutics Reports Primary Endpoint Met in Pivotal Phase 3 Trial of Zilretta™ in Knee OsteoarthritisBy Nasdaq OMXFeb 16, 2016, 9:01 PM UTC
BusinessCoherus and Baxalta Announce CHS-0214 (Investigational Etanercept Biosimilar) Met Primary Efficacy Endpoint in Phase 3 Rheumatoid Arthritis Clinical Study (RaPsODY)By Nasdaq OMXJan 11, 2016, 11:45 AM UTC
BusinessOcera Announces Complete Plasma Data From Pilot Phase 1 Study for Orally-Available OCR-002 in Development for the Prevention of Chronic Hepatic EncephalopathyBy Nasdaq OMXJan 8, 2016, 2:05 PM UTC
